News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
109
Sources here
12
Companies here
1
Search results Stored financial headlines

Active search

109 matching headlines

Ticker or company: RILYZMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Investing.com Analyst action Main company 🇺🇸 United States

B.Riley reiterates Buy on Bandwidth stock, keeps $85 price target

B.Riley reiterated a Buy rating and an $85.00 price target on Bandwidth Inc. following strong second-quarter fiscal 2026 results that exceeded consensus estimates. Despite a recent stock decline, the company saw significant year-over-year growth in its core Cloud Communications business and announced increased full-year …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
marketscreener.com Deals and strategy Main company 🇺🇸 United States

B. Riley Raises Price Target on Lantheus Holdings to $129 From $97, Keeps Buy Rating

B. Riley has increased its price target for Lantheus Holdings (LNTH) to $129 from $97, while maintaining a Buy rating on the stock. This adjustment reflects a positive outlook for the radiopharmaceutical company. Lantheus Holdings focuses on products for oncology, neurology, and cardiology, including …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

B. Riley Financial Upgrades Ribbon Communications (NASDAQ:RBBN) to Buy

B. Riley Financial upgraded Ribbon Communications (NASDAQ:RBBN) to a "buy" rating from "neutral," setting a $3.30 price target that suggests a 61% upside. This upgrade contributes to a "Moderate Buy" consensus rating among analysts, despite Ribbon Communications reporting a larger-than-expected quarterly loss and a …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Market update Main company 🇺🇸 United States

Capricor Therapeutics Shares Fall After B. Riley, Roth Capital Downgrades

Capricor Therapeutics (CAPR) shares fell following downgrades from B. Riley and Roth Capital. Both firms lowered their ratings to Neutral from Buy due to recent clinical trial results for the company's Duchenne muscular dystrophy drug. The downgrades reflect concerns about the drug's efficacy and …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Market source Analyst action Main company 🇺🇸 United States

B. Riley keeps $66 Applied Digital target after fiscal Q4 EBITDA beat

B. Riley Securities maintained its Buy rating and $66 price target for Applied Digital (NASDAQ: APLD) after the company surpassed fiscal fourth-quarter adjusted EBITDA estimates, reporting $42.4 million against a $24.6 million B. Riley estimate. The strong performance was partly driven by tenant fit-out …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

B. Riley Financial Cuts AXT (NASDAQ:AXTI) Price Target to $52.00

B. Riley Financial has lowered its price target for AXT (NASDAQ:AXTI) to $52.00 from $73.00, while maintaining a "neutral" rating. This new target implies an 8.6% potential upside for the semiconductor company. Despite beating recent quarterly earnings and revenue estimates, AXT continues to report …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
marketscreener.com Analyst action Main company 🇺🇸 United States

B. Riley Downgrades Capricor Therapeutics to Neutral From Buy, Adjusts PT to $10 From $63

B. Riley has downgraded Capricor Therapeutics (CAPR) from a "Buy" rating to "Neutral" and significantly reduced its price target from $63 to $10. This follows recent news regarding the company's Duchenne Muscular Dystrophy therapy and a lease agreement for a new headquarters. Capricor Therapeutics …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
www.marketscreener.com Analyst action Main company 🇺🇸 United States

B. Riley Adjusts Price Target on AXT to $52 From $73, Maintains Neutral Rating

B. Riley has adjusted its price target for AXT, Inc. (AXTI) down to $52 from $73, while maintaining a Neutral rating on the stock. This update comes alongside the announcement that AXT, Inc. will release its Q2 2026 earnings on July 30 and has …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

RILY|B Riley Financial Inc|Price:6.627|Chg%:-0.173

B. Riley Financial Inc. (RILY) has a relatively healthy fundamental score and high growth potential, though its stock is considered fairly valued within its industry. Institutional ownership is high, but the stock price is expected to trend down in the medium term, currently trading …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

RILY|B Riley Financial Inc|Price:6.800|Chg%:-0.080

B. Riley Financial, Inc. is a diversified financial services company with segments including Capital Markets, Wealth Management, Financial Consulting, Communications, and Consumer Products. The company's top shareholder is Mr. Bryant R. Riley, and as of Q1 2026, 319 institutions hold shares, with institutional shareholding …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

B Riley Financial Inc (RILY) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of B Riley Financial Inc (RILY), focusing on its current price momentum, support and resistance levels, and various technical indicators and moving averages. While the stock is trading between identified support and resistance, making it suitable for range-bound …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GuruFocus Analyst action Main company 🇺🇸 United States

IMAX Maintained by B. Riley Securities -- Price Target Raised to $52

B. Riley Securities has maintained a 'Buy' rating for IMAX and raised its price target from $48.00 to $52.00, indicating confidence in the company's growth potential. However, GuruFocus identifies IMAX as 61.9% overvalued, with a GF Value™ of $26.85 against its current price of …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GuruFocus Analyst action Main company 🇺🇸 United States

VRNS Maintains Rating by B. Riley Securities -- Price Target Rai

B. Riley Securities has maintained a 'Buy' rating for Varonis Systems (VRNS) and increased its price target from $45.00 to $55.00, reflecting optimism about the company's growth in the cybersecurity sector. GuruFocus indicates VRNS is currently undervalued by 16.2% with a GF Value™ of …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

B. Riley Financial Forecasts Strong Price Appreciation for Varonis Systems (NASDAQ:VRNS) Stock

B. Riley Financial has raised its price target for Varonis Systems (NASDAQ:VRNS) to $55 from $45, reiterating a "buy" rating and indicating a potential upside of nearly 20%. This optimistic outlook follows Varonis's better-than-expected quarterly earnings and revenue growth of 26.9% year-over-year. Other analysts …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

B. Riley Highlights Top Education Stocks Amid Sector Challenges

B. Riley has updated its outlook on key education stocks, maintaining positive stances on Phoenix Education Partners (PXED), American Public Education Inc. (APEI), and Universal Technical Institute Inc. (UTI). Despite sector challenges, the firm adjusted price targets for PXED, citing strong cash flow and …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Analyst action Main company 🇺🇸 United States

B. Riley Adjusts Price Target on ADTRAN to $21 From $23, Maintains Buy Rating

B. Riley has adjusted its price target for ADTRAN (ADTN) to $21 from $23, while reaffirming a Buy rating on the stock. This revision comes as part of their ongoing analysis of the company.

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

B Riley names top semiconductor capital equipment stocks

B Riley has highlighted key investment opportunities in the semiconductor capital equipment sector, particularly in back-end and OSAT sub-sectors, driven by increasing AI demand and advanced packaging investments. The firm identifies Cohu (COHU), Camtek (CAMT), Amkor Technology (AMKR), and Kulicke and Soffa Industries (KLIC) …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GuruFocus Analyst action Main company 🇺🇸 United States

AGMB Initiated by B. Riley Securities -- Price Target Set at $34

B. Riley Securities analyst William Woods has initiated coverage on AgomAb Therapeutics (AGMB) with a "Buy" rating and a $34 price target. Despite a positive outlook due to its focus on developing innovative therapies for chronic fibrotic diseases, AGMB has a low GF Score™ …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

ADTRAN (NASDAQ:ADTN) Receives Buy Rating from B. Riley Financial

B. Riley Financial reiterated a "buy" rating for ADTRAN (NASDAQ:ADTN), setting a $21 price target, which implies over 100% upside, despite a reduction from their previous $23 target. Analyst sentiment for ADTRAN remains mixed but generally positive, with a consensus "Moderate Buy" rating and …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
www.marketscreener.com Analyst action Main company 🇺🇸 United States

B. Riley Cuts Price Target on Amkor Technology to $75 From $90, Keeps Neutral Rating

B. Riley has revised its price target for Amkor Technology, Inc. (AMKR) downwards to $75 from its previous $90 target, while maintaining a Neutral rating on the stock. This adjustment comes despite a recent uptick in Amkor's stock following a partnership announcement with Taiwan …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com South Africa Analyst action Main company 🇺🇸 United States

This Pharmaceutical Stock is a Top Pick at B. Riley By Investing.com

B. Riley has reiterated its Buy rating on Ovid Therapeutics, Inc., designating it as a top pick in the pharmaceutical sector. The firm highlights Ovid's compelling risk-reward profile despite significant year-to-date gains and points to multiple catalysts anticipated between late 2026 and early 2027 …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Traders Daily Market update Main company 🇺🇸 United States

(RILYT) Price Dynamics and Execution-Aware Positioning

This article analyzes the price dynamics of B. Riley Financial Inc. 6.00% Senior Notes Due 2028 (NASDAQ: RILYT), highlighting weak near-term sentiment but potential long-term strength. It outlines three AI-generated institutional trading strategies (Position, Momentum Breakout, and Risk Hedging) tailored for different risk profiles. …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Traders Daily Guidance Main company 🇺🇸 United States

Why (RILYG) Price Action Is Critical for Tactical Trading

This article provides a critical analysis of B. Riley Financial Inc. 5.00% Senior Notes Due 2026 (RILYG) for tactical trading, identifying a neutral near and mid-term outlook with a potential long-term positive bias. It highlights a mid-channel oscillation pattern and offers detailed institutional trading …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Traders Daily Market update Main company 🇺🇸 United States

The Technical Signals Behind (RILYN) That Institutions Follow

This article analyzes the technical signals for B. Riley Financial Inc. 6.50% Senior Notes Due 2026 (NASDAQ: RILYN). It identifies a neutral near and mid-term outlook with a positive long-term bias, noting a mid-channel oscillation pattern. The report provides three AI-generated trading strategies (Position, …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
eciks.org Analyst action Main company 🇺🇸 United States

B. Riley raises AST SpaceMobile to Buy rating, citing valuation opportunity after stock's sharp pullback from May highs

B. Riley upgraded AST SpaceMobile (ASTS) to Buy from Neutral, maintaining an $85 price target, despite a 44% decline in shares over six months. The upgrade follows AST SpaceMobile's $1 billion convertible senior notes offering, which analyst Mike Crawford believes provides sufficient capital for …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Market update Main company 🇺🇸 United States

Rubico Terminates $30 Million Equity Facility With B. Riley

Rubicon Technologies terminated its $30 million equity line of credit with B. Riley Principal Capital, citing the facility's misalignment with its current capital plan and an advantageous market position for future financing. The company plans to continue pursuing non-dilutive and strategic financing alternatives.

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

B. Riley Financial Issues Positive Forecast for Trevi Therapeutics (NASDAQ:TRVI) Stock Price

B. Riley Financial has increased its price target for Trevi Therapeutics (NASDAQ:TRVI) to $31 from $21, maintaining a "buy" rating and suggesting a 64% upside. While other analysts have a "Moderate Buy" consensus with an average target of $23.80, Weiss Ratings reiterated a "sell" …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GuruFocus Analyst action Main company 🇺🇸 United States

TRVI Maintains Buy by B. Riley Securities -- Price Target Raised to $31.00

B. Riley Securities has maintained a Buy rating for Trevi Therapeutics (TRVI) and increased its price target to $31.00 from $21.00, signaling strong confidence in the company's potential, especially for its Haduvio therapy. Despite this bullish analyst outlook, Trevi Therapeutics faces financial challenges with …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Market source Analyst action Main company 🇺🇸 United States

B. Riley keeps Hut 8 at Buy after second $9.8 billion Beacon Point lease

B. Riley Securities has maintained its Buy rating and $130 price target for Hut 8 after the company signed a second 15-year lease valued at $9.8 billion for 352 MW of IT capacity at its Beacon Point campus in Texas. This triple-net lease for …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GuruFocus Analyst action Main company 🇺🇸 United States

ASTS Upgraded by B. Riley Securities -- Rating Raised to Buy

AST SpaceMobile (ASTS) has been upgraded from a "Neutral" to a "Buy" rating by B. Riley Securities, with the price target maintained at $85.00. While GuruFocus indicates the stock is significantly undervalued with a GF Value™ of $488.29 against a current price of $57.80, …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Analyst action Main company 🇺🇸 United States

AST SpaceMobile Shares Rise After B. Riley Upgrade

This article reports on AST SpaceMobile (ASTS) shares rising following an upgrade from B. Riley. The upgrade reflects a positive outlook for the company's future prospects.

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GuruFocus Analyst action Main company 🇺🇸 United States

CNK Maintained by B. Riley Securities -- Price Target Lowered to $35

B. Riley Securities has maintained a Neutral rating on Cinemark Holdings (CNK) but lowered its price target to $35.00 from $36.00. While GuruFocus suggests the stock is undervalued by 4.8% at $30.27, mixed analyst sentiment and recent insider selling of $4.4 million warrant caution …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Seeking Alpha Analyst action Main company 🇺🇸 United States

AST SpaceMobile surges as B. Riley raises on valuation after selloff (ASTS:NASDAQ)

AST SpaceMobile (ASTS) saw its stock rise by 7.8% on Friday after B. Riley upgraded the company's rating to Buy from Neutral, setting an $85 price target. This upgrade follows a 44% slump in the shares over the past six months, with B. Riley …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

Cinemark (NYSE:CNK) Price Target Cut to $35.00 by Analysts at B. Riley Financial

B. Riley Financial has reduced its price target for Cinemark (NYSE:CNK) to $35.00 from $36.00, maintaining a "neutral" rating, which implies a potential 15% upside. This adjustment comes amidst mixed analyst sentiment, with Goldman Sachs upgrading the stock to neutral and Zacks downgrading it …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Analyst action Main company 🇺🇸 United States

B.Riley upgrades AST Spacemobile stock rating to Buy on funding

B.Riley upgraded AST Spacemobile (NASDAQ:ASTS) from Neutral to Buy, maintaining a price target of $85.00, following the company's successful pricing of $1 billion in convertible senior notes. Despite a 44% decline in share price since a previous downgrade, the company's strong liquidity and progress …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

B.Riley cuts Bitmine Immersion stock price target on staking miss

B.Riley has lowered its price target for Bitmine Immersion Technologies (OTC:BMNR) stock from $33 to $25, while maintaining a Buy rating, following the company's fiscal third-quarter 2026 results which saw staking revenue miss estimates. The shortfall was attributed to the pace of Ethereum staking …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context